The thrombin generation assay distinguishes inhibitor from non-inhibitor patients with severe haemophilia A

Haemophilia

Volumn 22, Issue 4, 2016, Pages e286-e291

  Mancuso, M E ^a   Chantarangkul, V ^a   Clerici, M ^a   Fasulo, M R ^a   Padovan, L ^a   Scalambrino, E ^a   Peyvandi, F ^a,b   Tripodi, A ^a,b   Santagostino, E ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

endogenous thrombin potential; F8 mutations; inhibitors; severe haemophilia A; thrombin generation assay

Indexed keywords

ALLOANTIBODY; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 ANTIBODY;

ADULT; ARTICLE; BLEEDING TENDENCY; BLOOD ANALYSIS; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; GENOTYPE; HEMOPHILIA A; HUMAN; MAJOR CLINICAL STUDY; MUTATION; PRIORITY JOURNAL; SCHOOL CHILD; THROMBIN GENERATION ASSAY; THROMBIN TIME;

EID: 84979072975     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/hae.12927     Document Type: Article

References (13)

1. Mannucci PM, Tuddenham EGD. The Hemophilias – from royal genes to gene therapy. N Engl J Med 2001; 344: 1773–9.
2. Verbruggen B, Meijer P, Novakova I, Van Heerde W. Diagnosis of factor VIII deficiency. Haemophilia 2008; 14: 76–82.
3. Al Dieri R, Peyvandi F, Santagostino E et al. The thrombogram in rare inherited coagulation disorders: its relation to clinical bleeding. Thromb Haemost 2002; 88: 576–82.
4. Chantarangkul V, Clerici M, Bressi C, Giesen PL, Tripodi A. Thrombin generation assessed as endogenous thrombin potential in patients with hyper- or hypo-coagulability. Haematologica 2003; 88: 547–54.
5. Beltràn-Miranda CP, Khan A, Jaloma-Cruz AR, Laffan MA. Thrombin generation and phenotypic correlation in haemophilia A. Haemophilia 2005; 11: 326–34.
6. Santagostino E, Mancuso ME, Tripodi A et al. Severe hemophilia with mild bleeding phenotype: molecular characterization and global coagulation profile. J Thromb Haemost 2010; 8: 737–43.
7. Luddington R, Baglin T. Clinical measurement of thrombin generation by calibrated automated thrombography requires contact factor inhibition. J Thromb Haemost 2004; 2: 1954–9.
8. Hemker HC, Giesen P, Al Dieri R et al. Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb 2003; 33: 4–15.
9. Verbruggen B, Novakova I, Wessels H, Boezeman J, van den Berg M, Mauser-Bunschoten E. The Nijmegen modification of the Bethesda assay for factor VIII: C inhibitors: improved specificity and reliability. Thromb Haemost 1995; 73: 247–51.
10. Oldenburg J, El-Maarri O, Schwaab R. Inhibitor development in correlation to factor VIII genotypes. Haemophilia 2002; 8: 23–9.
11. Salinas V, Carmona R, Mohammed BM, Martin EJ, Brophy DF, Young G. Is some better than none: are TEG and TGA profiles different in severe FVIII-deficient patients with inhibitors? Haemophilia 2015; 21: 398–404.
12. Dargaud Y, Béguin S, Lienhart A et al. Evaluation of thrombin generation capacity in plasma from patients with haemophilia A and B. Thromb Haemost 2005; 93: 475–80.
13. Dargaud Y, Lienhart A. Negrier C Prospective assessment of thrombin generation test for dose monitoring of bypassing therapy in hemophilia patients with inhibitors undergoing elective surgery. Blood 2010; 116: 5734–7.